Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Cholangiocarcinoma × tremelimumab × Clear all

Phase

Phase 2 5 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 6 Urinary Bladder Neoplasms 3 Prostatic Neoplasms 3 Neoplasms 3 Breast Neoplasms 3 Melanoma 2 Lung Neoplasms 2 Liver Neoplasms 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Squamous Cell 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Adenocarcinoma Of Esophagus 2 Uterine Cervical Neoplasms 1 Testicular Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Peritoneal Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Mesothelioma 1 Lymphoma, T-Cell, Cutaneous 1 Kidney Neoplasms 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1

Interventions

Gemcitabine 7 pembrolizumab 6 Cisplatin 4 durvalumab 3 Oxaliplatin 3 Nivolumab 3 fludarabine 2 Ipilimumab 2 Drug Therapy 2 Cyclophosphamide 2 Capecitabine 2 130-nm albumin-bound paclitaxel 2 tremelimumab 1 trametinib 1 tivozanib 1 tislelizumab 1 silmitasertib 1 pertuzumab 1 olutasidenib 1 lenvatinib 1 enasidenib 1 devimistat 1 derazantinib 1 atezolizumab 1 aldesleukin 1 Specimen Handling 1 Sorafenib 1 Ritonavir 1 Radiation 1 Magnetic Resonance Spectroscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04989218 2024-11-05

ICC

University of Alabama at Birmingham

Phase 1/2 Terminated

1 enrolled 11 charts

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡